Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm
- PMID: 26155232
- PMCID: PMC4304512
- DOI: 10.14701/kjhbps.2013.17.4.157
Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm
Abstract
Backgrounds/aims: Tumor recurrence is very common after hepatic resection of hepatocellular carcinoma (HCC) ≥10 cm. The purpose of this study was to validate the prognostic significance of the preoperative alkaline phosphatase (ALP) level and early intrahepatic metastasis in HCC patients who underwent resection of large HCC.
Methods: Clinical data of 100 large HCC patients who underwent liver resection were retrospectively reviewed. All of them underwent protocol transarterial chemoinfusion (TACI) at 1 month.
Results: Median tumor diameter was 13.8 cm, and 94% were single lesions. Systematic and non-systematic resections were performed in 91% and 9%, respectively, with R0 resection achieved in 84%. Overall 1-, 3- and 5-year survival rates were 76%, 38.5%, and 30.4%, respectively. Univariate analyses on patient survival revealed that intrahepatic metastasis on 1-month protocol TACI was the only significant risk factor (p=0.002). Mean ALP values according to the intrahepatic metastasis on 1-month protocol TACI were 124.6±76.9 IU/L and 145.1±92.6 IU/L, which did not show a statistical difference (p=0.23).
Conclusions: In patients with large HCC, 1-month protocol TACI combined with hepatic resection may contribute to the early detection and timely treatment of potentially preexisting metastatic lesions.
Keywords: Hepatocellular carcinoma; Intrahepatic metastasis; Recurrence; Transarterial chemoinfusion.
Figures





Similar articles
-
Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.Br J Surg. 2007 Mar;94(3):320-6. doi: 10.1002/bjs.5622. Br J Surg. 2007. PMID: 17205495
-
[Disappearance of intrahepatic bile duct hepatocellular carcinoma after endoscopic retrograde cholangiopancreatography and transarterial chemoinfusion: a case report].Korean J Gastroenterol. 2014 May;63(5):321-4. doi: 10.4166/kjg.2014.63.5.321. Korean J Gastroenterol. 2014. PMID: 24870306 Korean.
-
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29262506 Chinese.
-
Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.Clin Transl Oncol. 2018 Jun;20(6):729-739. doi: 10.1007/s12094-017-1779-y. Epub 2017 Nov 6. Clin Transl Oncol. 2018. PMID: 29110217
-
Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.Chin Med J (Engl). 1999 Oct;112(10):887-91. Chin Med J (Engl). 1999. PMID: 11717970 Review.
Cited by
-
Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm.J Liver Cancer. 2021 Mar;21(1):45-57. doi: 10.17998/jlc.21.1.45. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384269 Free PMC article.
-
Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.J Gastrointest Surg. 2016 Nov;20(11):1807-1820. doi: 10.1007/s11605-016-3187-y. Epub 2016 Jun 16. J Gastrointest Surg. 2016. PMID: 27311982
-
Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.World J Surg. 2018 Aug;42(8):2579-2591. doi: 10.1007/s00268-018-4468-2. World J Surg. 2018. PMID: 29340726
References
-
- Lee SG, Hwang S, Jung JP, et al. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg. 2007;94:320–326. - PubMed
-
- Poon RT, Ngan H, Lo CM, et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol. 2000;73:109–114. - PubMed
-
- Mok KT, Wang BW, Lo GH, et al. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg. 2003;197:730–738. - PubMed
-
- Yeh CN, Lee WC, Chen MF. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol. 2003;10:1070–1076. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources